Germany's Top Companies: GENEART has Reached the "Entrepreneur of the
Year 2007" Final
- Ernst & Young recognizes the best mid-tier companies in Germany.
- Stellar growth rates and a push toward innovation have earned the
GENEART team a place in the final.
- The popular prize for top performing companies will be awarded on
October 19, 2007, in the Old Opera House (Alte Oper) in Frankfurt.
Regensburg, October 10, 2007 - The GENEART AG has reached the final
in the industrial category of the "Entrepreneur of the Year 2007"
competition. The award recognizes first rate entrepreneurial
accomplishments. Only the fastest growing and most innovative
companies in Germany are nominated for the Entrepreneur of the Year
Award.
The accounting and advisory services firm Ernst & Young awards the
prize to the best German mid-tier companies. Formidable award
criteria distinguish this prize from others. As Wolfgang Glauner,
organizer and project manager of the prize, points out, "To evaluate
the achievements of a candidate we don't just look at the company's
key figures but also rely on personal interviews."
An independent jury of outstanding experts now faces a tough
decision. The jury will determine the winners in the categories
industry, commerce, services, information, and communications
technologies/media and also have to elect a winner among the
start-ups. On October 19, 2007, the winners will be announced in a
festive ceremony at the Old Opera House (Alte Oper) in Frankfurt
(Germany). On this occasion, all finalists are also recognized and
inducted into the Entrepreneur of the Year Club, which is the "Hall
of Fame" for entrepreneurs in Germany.
The GENEART AG is the leading global producer of synthetic genes and
specialist in synthetic biology. On average, the publicly traded
company has increased its sales by
70 % every year since its inception. The trend is expected to
continue with a significant boost in sales for 2007. With now more
than 140 employees, the GENEART AG provides key technologies
worldwide, which allow a significantly faster and more cost-effective
access to genes than the traditional methods in molecular biology.
"Currently, the production of synthetic genes in general and the
GENEART technology platform in particular transition from niche
applications to standard products for molecular biology research.
Meanwhile, every one of the top 20 pharmaceutical companies, many
international biotechnology companies and renowned research
institutes take advantage of the GENEART service portfolio", comments
Professor Ralf Wagner, CEO of GENEART.
For further inquiries, please contact:
Bernd Merkl
GENEART AG
Josef-Engert-Str. 11
D-93053 Regensburg
Germany
Phone: +49-(0)941-942 76 - 638
Fax: +49-(0)941-942 76 - 711
ir@geneart.com
www.geneart.com
Legal Information
This document may contain estimates, prognoses and opinions about
company plans and objectives, products or services, future results,
opinions about these results or opinions leading up to these results.
All these projections into the future are subject to risk,
uncertainty and unforeseeable change outside the control of the
GENEART Group. Many factors may lead to actual results, which
considerably deviate from the given projections for these results.
About GENEART AG
In 2000, GENEART entered the gene synthesis market and has since
become the global market leader. Today, the company is one of the
leading specialists in the synthetic biology field. Experts at
GENEART provide key technologies for the development and production
of new therapeutics and vaccines. Customers also take advantage of
GENEART services to customize enzyme attributes, such as the
attributes of enzymes used as detergent additives, and to construct
bacteria, which produce complex biopolymers or break down polymers,
such as synthetics, petroleum components, etc. Our production and
service spectrum spans a wide range, from the production of synthetic
genes according to DIN EN ISO 9001-2000, to the creation of gene
libraries in the combinatorial biology, to the development and
production of DNA-based biologically active substances. The GENEART
AG in Regensburg (Germany) and the subsidiary GENEART Inc. in Toronto
(Canada) employ more than 140 people. Since May 2006, GENEART is
listed on the German Stock Exchange.
About the "Entrepreneur of the Year" Competition:
Ernst & Young organizes "Entrepreneur of the Year" competitions in 50
countries worldwide. In Germany, the year 2007 is the 11th year of
honoring companies with the award. The prizes are awarded in
recognition of first-rate entrepreneurial performance. An impartial
jury of first rate business executives and scientists selects the
"Entrepreneur of the Year" in the categories industry, commerce,
services, information and communications technology/media as well as
in the start-up division. Well-known companies and the media support
the competition as partners, among them are BMW, IKB Deutsche
Industriebank, Capgemini, the national newspaper Frankfurter
Allgemeine and the Manager Magazine.
About Ernst & Young:
The business services firm Ernst & Young AG (Certified Public
Accountants and Tax Consultants) with headquarters in Stuttgart is
one of the three dominant German business auditing and advisory
firms. The firm is part of the International Ernst & Young Global
network. Ernst & Young tax consultants rank first among German
auditors and tax consultants. In Germany, Ernst & Young employs 6,250
people in 21 locations. In 2005/2006, the firm achieved roughly EURO
1.01B in sales. The 114,000 Ernst & Young Global employees achieved
US$ 18.4B in sales in the same period.
The German Ernst & Young network partners with large and mid-sized
companies offering a comprehensive portfolio of business services as
auditors and tax consultants. The firm also supports companies as
advisors in business transactions as well as in management, risk and
real estate decisions.
